156 related articles for article (PubMed ID: 22619383)
1. A case of valproate-induced encephalopathy.
Hong L; Schutz J; Nance M
Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
[No Abstract] [Full Text] [Related]
2. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
Al-sharefi A; Bilous R
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
[TBL] [Abstract][Full Text] [Related]
3. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
Elgudin L; Hall Y; Schubert D
Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
[TBL] [Abstract][Full Text] [Related]
4. Treatment of valproate-induced hyperammonemia.
Stewart JT
J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
[No Abstract] [Full Text] [Related]
5. Valproate-induced hyperammonemic encephalopathy.
Murphy JV
Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
[No Abstract] [Full Text] [Related]
6. Clinical alertness to valproic acid-induced hyperammonemia--two case reports.
Shan JC; Hsieh MH; Liu CC; Wen CC; Liu CM
J Psychopharmacol; 2010 Jun; 24(6):943-5. PubMed ID: 19304858
[No Abstract] [Full Text] [Related]
7. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
Fassi G; Igoa A; Liste OA
Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
[TBL] [Abstract][Full Text] [Related]
8. Valproate-associated hyperammonemic encephalopathy.
Wadzinski J; Franks R; Roane D; Bayard M
J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
[TBL] [Abstract][Full Text] [Related]
9. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of divalproex extended release in psychiatric patients.
Jackson RS; Venkataraman S; Atkins RB; Owens M
Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
[No Abstract] [Full Text] [Related]
11. Valproate-induced encephalopathy in a comorbid elderly woman.
Gandolfo F; Parodi MN; Corsini GP; Odetti P; Serafini G; Monacelli F
Psychogeriatrics; 2017 May; 17(3):208-209. PubMed ID: 28093879
[No Abstract] [Full Text] [Related]
12. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
[TBL] [Abstract][Full Text] [Related]
13. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
14. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
Longo LP
Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
[No Abstract] [Full Text] [Related]
15. Valproate-related hyperammonemic encephalopathy: report of 1 case.
Selvi Y; Annagur BB; Sayin AA; Akbaba N
J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
[No Abstract] [Full Text] [Related]
16. Risperidone, a risk factor for valproate-induced encephalopathy?
Rodrigues-Silva N; Venâncio Â; Bouça J
Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
Dealberto MJ
Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
[TBL] [Abstract][Full Text] [Related]
18. [Hyperammoniemia and central pontine myelinolysis in a patient with Sjögren syndrome and chronic valproate use].
Berlot G; Battaglia K; Ukmar M
Recenti Prog Med; 2008 Oct; 99(10):502-4. PubMed ID: 19040128
[TBL] [Abstract][Full Text] [Related]
19. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
Schwarz S; Georgiadis D; Schwab S; Gehlen F; Mayatepek E; Zoubaa S
J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):90-1. PubMed ID: 12082063
[No Abstract] [Full Text] [Related]
20. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
